Tau polymorphisms are not associated with Alzheimer's disease

Neuroscience Letters

Volumn 284, Issue 1-2, 2000, Pages 77-80

  Kwon, Jennifer M ^a   Nowotny, Petra ^a   Shah, Purvi K ^a   Chakraverty, Sumi ^a   Norton, Joanne ^a   Morris, John C ^a   Goate, Alison M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Polymorphism; Tau

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

AGED; ALZHEIMER DISEASE; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; TAU PROTEINS;

EID: 0034697214     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00972-1     Document Type: Article

References (18)

1. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8:1999;711-715.
2. Buée L., Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9:1999;181-193.
3. Bullido M.J., Aldudo J., Frank A., Coria F., Avila J., Valdivieso F. A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett. 278:2000;49-52.
4. Conrad C., Amano N., Andreadis A., Xia Y., Namekataf K., Oyama F., Ikeda K., Wakabayashi K., Takahashi H., Thal L.J., Katzman R., Shackelford D.A., Matsushita M., Masliah E., Sawa A. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci. Lett. 250:1998;135-137.
5. Conrad C., Andreadis A., Trojanowski J.Q., Dickson D.W., Kang D., Chen X.H., Wiederholt W., Hansen L., Masliah E., Thal L.J., Katzman R., Xia Y., Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41:1997;277-281.
6. Crawford F., Freeman M., Town T., Fallin D., Gold M., Duara R., Mullan M. No genetic association between polymorphisms in the tau gene and Alzheimer's disease in clinic or population based samples. Neurosci. Lett. 266:1999;193-196.
7. Evans D.A., Beckett L.A., Field T.S., Feng L., Albert M.S., Bennett D.A., Tycko B., Mayeux R. Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. J. Am. Med. Assoc. 277:1997;822-824.
8. Feany M.B., Dickson D.W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann. Neurol. 40:1996;139-148.
9. Foster N.L., Wilhelmsen K., Sima A.A.F., Jones M.Z., Damato C.J., Gilman S., Conference Participants. Frontotemporal dementia and parkinsonism linked to Chromosome 17-a consensus conference. Ann. Neurol. 41:1997;706-715.
10. Higgins J.J., Litvan I., Pho L.T., Li W., Nee L.E. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology. 50:1998;270-273.
11. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickeringbrown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., Degraaff E., Wauters E., Vanbaren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association Of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
12. Lilius L., Fabre S.F., Basun H., Forsell C., Axelman K., Andreadis A., Viitanen M., Winblad B., Fratiglioni L., Lannfelt L. Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer's disease. Neurosci. Lett. 277:1999;29-32.
13. Morris H.R., Janssen J.C., Bandmann O., Daniel S.E., Rossor M.N., Lees A.J., Wood N.W. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol. Neurosurg., Psychiatry. 66:1999;665-667.
14. Oliva R., Tolosa E., Ezquerra M., Molinuevo J.L., Valldeoriola F., Burguera J., Calopa M., Villa M., Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch. Neurol. 55:1998;1122-1124.
15. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43:1998;815-825.
16. Rizzu P., Van Swieten J.C., Joosse M., Hasegawa M., Stevens M., Tibben A., Niermeijer M.F., Hillebrand M., Ravid R., Oostra B.A., Goedert M., van Duijn C.M., Heutink P. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 64:1999;414-421.
17. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21:1998;428-433.
18. Talbot C., Lendon C.L., Craddock N., Shears S., Morris J.C., Goate A. Protection against Alzheimer's disease with ApoE ε2. Lancet. 343:1994;1432-1433.